Long-term bevacizumab is safe and effective in managing small bowel angioectasias bleeding refractory to conventional treatments: a case report.

Saved in:
Bibliographic Details
Title: Long-term bevacizumab is safe and effective in managing small bowel angioectasias bleeding refractory to conventional treatments: a case report.
Authors: Compare D; Department of Clinical Medicine and Surgery, Gastroenterology, University Federico II, Naples, Italy., Sgamato C; Department of Clinical Medicine and Surgery, Gastroenterology, University Federico II, Naples, Italy., Rocco A; Department of Clinical Medicine and Surgery, Gastroenterology, University Federico II, Naples, Italy., Minieri S; Department of Clinical Medicine and Surgery, Gastroenterology, University Federico II, Naples, Italy., Cinque S; Department of Clinical Medicine and Surgery, Gastroenterology, University Federico II, Naples, Italy., Giordano F; Department of Clinical Medicine and Surgery, Gastroenterology, University Federico II, Naples, Italy., Nardone G; Department of Clinical Medicine and Surgery, Gastroenterology, University Federico II, Naples, Italy.
Source: Gastroenterology report [Gastroenterol Rep (Oxf)] 2024 Jul 06; Vol. 12, pp. goae070. Date of Electronic Publication: 2024 Jul 06 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press and Science Digestive Pub. Co Country of Publication: England NLM ID: 101620508 Publication Model: eCollection Cited Medium: Print ISSN: 2052-0034 (Print) NLM ISO Abbreviation: Gastroenterol Rep (Oxf) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2052-0034
DOI:10.1093/gastro/goae070